February 2020 in “Acta Scientific Women's Health” This narrative review discusses the various symptoms, diagnosis challenges, and treatment options for polycystic ovary syndrome, emphasizing the need for increased awareness and early diagnosis to prevent complications.
6 citations
,
August 2023 in “European journal of endocrinology” This review discusses the 2023 International Guideline for PCOS assessment and management, highlighting updated evidence-based recommendations and practice points aimed at improving care and health outcomes, but notes that research quality remains generally low to moderate.
39 citations
,
January 2012 in “Reproductive Biology and Endocrinology” In this study, the prevalence of polycystic ovary syndrome among women seeking primary healthcare in Salvador, Brazil, was found to be 8.5% using the Rotterdam criteria.
May 2026 in “International Journal of Current Pharmaceutical Review and Research” This article discusses the causes of polycystic ovary syndrome, including environmental pollutants, genetics, and oxidative stress, and explains how these factors contribute to symptoms like irregular menstrual cycles and obesity without reporting new clinical results.
October 2023 in “IntechOpen eBooks” This book chapter reviews the genetic and epigenetic factors influencing PCOS, particularly in a global context and specific to India, and reports no new clinical findings.
16 citations
,
September 2018 in “Journal of Molecular Liquids” This study investigated a nanostructured system using PS-b-PAA diblock copolymer for incorporating the hydrophobic photosensitizer ClAlPc, finding it effective in causing cellular damage in Caco-2 cells under light while demonstrating no cytotoxicity without light, suggesting its potential use in photodynamic therapy.
21 citations
,
May 2021 in “Patient education and counseling” This study explored the challenges faced by both clinicians and women with polycystic ovary syndrome in managing the condition, highlighting issues with treatment options, misinformation, and differing expectations in care.
January 2023 in “European journal of biology and medical science research” This review discusses the diverse prevalence, symptoms, and diagnostic criteria of Polycystic Ovary Syndrome in women and highlights that treatment varies based on symptom presentation and long-term management.
991 citations
,
January 2011 in “Nature Reviews Endocrinology” This paper reviews the diagnostic criteria, associated morbidities, and possible evolutionary advantages of polycystic ovary syndrome, but does not report any new findings.
May 2024 in “Reproductive BioMedicine Online” This systematic review found that interactions between patients with polycystic ovary syndrome and healthcare professionals often face challenges due to insufficient information sharing, inadequate patient support, and health system barriers.
April 2016 in “Journal of The American Academy of Dermatology” This study found that inpatient dermatology consultations at a large tertiary care center often led to significant treatment changes, especially for complex skin conditions potentially linked to systemic diseases.
January 2016 in “cIRcle (University of British Columbia)” This literature review discusses the need for a clinical practice guideline to help Canadian Nurse Practitioners in diagnosing and managing PCOS, noting its complexity and lack of existing guidelines.
September 2023 in “International Journal For Multidisciplinary Research” In this case report, a 29-year-old woman with PCOS experienced significant improvement in symptoms and ultrasound findings after three months of Ayurvedic treatment, suggesting potential benefits of adherence to Ayurvedic principles for managing PCOS.
2 citations
,
January 2016 in “Knowledge Commons (Lakehead University)” This study investigates the experiences of women with PCOS to increase understanding, reduce stigma, and enhance education about the syndrome for all women.
April 2017 in “Journal of Investigative Dermatology” This study suggests that PKCß plays a critical role in modulating the dermal inflammatory microenvironment in response to dietary lipids in mice.
February 2025 in “International Journal of Pharmaceutical Research and Applications” This article reviews the symptoms, diagnosis, and management of polycystic ovary syndrome, emphasizing lifestyle changes and medical interventions, but presents no new findings.
January 2019 in “ISGE series” This review discusses the criteria, diagnosis, and treatment options for polycystic ovary syndrome and reports no new clinical results; it highlights the need for further research on causative treatments.
July 2025 in “Journal of Pharmacognosy and Phytochemistry” This review explores the potential benefits of plant-based diets, herbal remedies, and phytochemicals for managing PCOS, suggesting they may help regulate menstrual cycles, improve metabolic parameters, and reduce androgen levels, offering a promising, holistic approach to treatment.
April 2016 in “Journal of The American Academy of Dermatology” This study found that dermatology consultations in a tertiary care center often led to treatment changes, particularly for complex dermatologic conditions potentially linked to systemic disease.
3 citations
,
February 2018 in “InTech eBooks” This chapter discusses the current developments in Traditional Chinese Medicine for treating PCOS but reports no new clinical results, emphasizing the need for further research in this area.
6 citations
,
January 2015 in “International journal of reproduction, contraception, obstetrics and gynecology” In this study, metabolic syndrome was common among women with polycystic ovarian syndrome, with a significant association with higher BMI and prevalent dyslipidemia.
1 citations
,
February 2021 in “International journal of reproduction, contraception, obstetrics and gynecology” This study found a 6.11% prevalence of polycystic ovary syndrome among gynecology out-patients, noting that obese women with PCOS had more severe ovulatory dysfunction.
29 citations
,
March 2015 in “Clinical Endocrinology” This study found that women with polycystic ovary syndrome in the UK show significant differences in phenotypic and metabolic characteristics based on ethnicity, age, and obesity, influencing management strategies.
This study found that most participants had limited awareness of PCOS and its major risk factors, underscoring a need for increased education on the condition.
This study found that women with PCOS had significant hormonal imbalances, increased central obesity, and a lower 2D:4D digit ratio, suggesting prenatal androgen exposure may play a role in the condition's development.
September 2005 in “Morecambe Bay medical journal” This article discusses the complex condition of polycystic ovary syndrome and its modern management, emphasizing it as a multisystem disorder with significant impacts on patients' well-being.
87 citations
,
July 2018 in “Nursing Clinics of North America” This review discusses the diagnostic criteria and treatment options for polycystic ovary syndrome focusing on metabolic subtypes and reports no clinical results.
42 citations
,
January 2024 in “Frontiers in Endocrinology” This review discusses polycystic ovary syndrome treatments, focusing on the potential benefits and safety of herbs and phytochemicals, and reports no new clinical results.
9 citations
,
July 2009 in “Journal Of Endocrinology, Metabolism And Diabetes Of South Africa” The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.
June 2026 in “Reproduction and Fertility” In this study, researchers highlighted that PCOS involves not only hormonal imbalances but also significant changes in the microbiome and immune system, which complicate its impact on fertility and suggest potential for new diagnostic and therapeutic strategies.